According to the company's website, "The Cannabis Growth Opportunity Corporation’s investment objectives are to provide holders of Common Shares long-term total return through capital appreciation by investing in an actively managed portfolio of securities of public and private companies operating in, or that derive a significant portion of their revenue or earnings from, products or services related to the cannabis industry."
To add further clarification to the company's strategy, they note that "CGOC Management Corp. will act as the manager and promoter of the Corporation and will provide all management services required by the Corporation."
The Team Behind Cannabis Growth Opportunity Corp.
The team behind Cannabis Growth Opportunity Corp. brings tremendous experience from a handful of different and relevant industries to the company.
Jamie Blundell, President and CEO, brings more than 25 years of experience in senior leadership roles and managing teams of over 1,000 employees. With extensive experience in mergers and acquisitions, and private equity, it's nice knowing there's a pro at the reigns.
Bruce Campbell, Chief Investment Officer, is often quoted in Bloomberg, The Globe and Mail, and Small Cap Power regarding investments in the cannabis space and more. His media influence and investment expertise will allow the company to reach investors on multiple channels, allowing the company to promote itself.
Paul Anderson, CPA, the company's CFO brings his cannabis-specific experience to the table as he currently serves as a director of Canada House Wellness Group.
This is only a small sampling of the rock-solid team that the company has built.
According to the CSE's press release, shares of Cannabis Growth Opportunity Corporation will trade under the symbol CGOC, while warrants will trade under the symbol CGOC.WT.
There are currently 15,513,251 common shares outstanding, as well as 15,513,250 warrants. There is a total of 35,500,000 shares reserved for issuance.
Both the common shares as well as the warrants are expected to begin trading on Monday, January 29th, 2018.
The warrants to be listed on the CSE entitle the holder to acquire one common share at a price of $2.50 CAD, subject to adjustment, on or prior to 5:00 PM E.S.T. on the expiry date, January 26, 2020. The warrants are subject to an accelerated expiry should certain conditions be met.